19

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                    FORM 10-Q

(MARK ONE)

(X)  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
     ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2004

                                                                  OR

(    )  TRANSITION  REPORT  PURSUANT  TO SECTION  13 OR 15(D) OF THE  SECURITIES
     EXCHANGE  ACT OF 1934 FOR THE  TRANSITION  PERIOD  FROM  ______  TO  ______
     COMMISSION FILE NUMBER 1-10596

                             ESCO TECHNOLOGIES INC.

             (Exact name of registrant as specified in its charter)


MISSOURI                                                             43-1554045
(State or other jurisdiction of                                (I.R.S. Employer
incorporation or organization)                              Identification No.)

8888 LADUE ROAD, SUITE 200
ST. LOUIS, MISSOURI                                                  63124-2090
(Address of principal executive offices)                             (Zip Code)

        Registrant's telephone number, including area code:(314) 213-7200

     Indicate  by check mark  whether the  registrant  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant  was required to file such  reports) and (2) has been subject to such
filing requirements for the past 90 days. Yes X No

     Indicate by check mark whether the registrant is an  accelerated  filer (as
defined in Rule 12b-2 of the Exchange Act). Yes X No___

The number of shares of the registrant's stock outstanding at April 30, 2004 was
12,936,295.




PART I.  FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

                     ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (Unaudited)
                (Dollars in thousands, except per share amounts)

                                                      Three Months Ended
                                                           March 31,
                                                           ---------

                                                   2004              2003
                                                   ----              ----

  Net sales                                   $  102,171            101,996
  Costs and expenses:
     Cost of sales                                70,781            69,640
      Selling, general and administrative
      expenses                                    19,111            18,327
     Interest income                                (483)             (158)
     Other, net                                      513             2,300
                                                     ---             -----
       Total costs and expenses                   89,922            90,109
                                                  ------            ------
  Earnings before income taxes                    12,249            11,887
  Income tax expense                               4,684             4,549
                                                   -----             -----
  Net earnings from continuing operations          7,565             7,338

  Loss from discontinued operations, net of
  tax of $551 and $627, respectively              (2,200)           (1,707)
                                                  ------            ------


  Net earnings                                 $   5,365             5,631
                                                  ------             -----

  Earnings (loss) per share:
    Basic   -   Continuing operations          $     0.59        $   0.58
            -   Discontinued operations             (0.17)          (0.13)
                                                    -----           -----
            -   Net earnings                   $     0.42        $   0.45
                                                    =====           =====

    Diluted -   Continuing operations          $     0.57        $   0.56
            -   Discontinued operations             (0.17)          (0.13)
                                                    -----           -----
            -   Net earnings                   $     0.40        $   0.43
                                                    =====            ====

See accompanying notes to consolidated financial statements.




                     ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (Unaudited)
                (Dollars in thousands, except per share amounts)

                                                         Six Months Ended
                                                             March 31,
                                                             ---------

                                                      2004              2003
                                                      ----              ----

   Net sales                                     $  198,567           200,285
   Costs and expenses:
      Cost of sales                                 137,051           136,197
       Selling, general and administrative
       expenses                                      37,880            36,391
      Interest income                                  (519)             (269)
      Other, net                                      1,127             2,816
                                                      -----             -----
        Total costs and expenses                    175,539           175,135
                                                    -------           -------
   Earnings before income taxes                      23,028            25,150
   Income tax expense                                 8,875             9,338
                                                      -----             -----
   Net earnings from continuing operations           14,153            15,812

   Loss from discontinued operations, net of
   tax of $1,208 and $1,345, respectively            (2,637)           (3,629)
                                                     ------            ------

   Net earnings                                   $  11,516            12,183
                                                     ======            ======

   Earnings (loss) per share:
     Basic   -   Continuing operations            $     1.10        $   1.26
             -   Discontinued operations               (0.20)          (0.29)
                                                       -----           -----
             -   Net earnings                     $     0.90        $   0.97
                                                       =====            ====

     Diluted -   Continuing operations            $     1.06        $   1.21
             -   Discontinued operations               (0.19)          (0.28)
                                                       -----           -----
             -   Net earnings                     $     0.87        $   0.93
                                                       =====            ====

See accompanying notes to consolidated financial statements.




                     ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS
                             (Dollars in thousands)

                                                        March 31, September 30,
                                                             2004         2003
                                                             ----         ----
 ASSETS                                                   (Unaudited)
 Current assets:
    Cash and cash equivalents                             $ 40,672      31,285
    Accounts receivable, less allowance for doubtful
      accounts of $653 and $734, respectively               66,314      69,379
    Costs and estimated earnings on long-term
      contracts, less progress billings of
      $8,331 and $5,089, respectively                        4,456       4,663
    Inventories                                             51,080      48,432
    Current portion of deferred tax assets                  23,446      24,187
    Other current assets                                     4,817       6,549
    Current assets from discontinued operations             23,405      21,640
                                                            ------      ------
        Total current assets                               214,190     206,135
                                                           -------     -------
 Property, plant and equipment, at cost                    127,988     122,791
 Less accumulated depreciation and amortization             56,575      51,622
                                                            ------      ------
        Net property, plant and equipment                   71,413      71,169
 Goodwill                                                   68,886      68,653
 Deferred tax assets                                        16,432      16,618
 Other assets                                               15,958      14,081
 Other assets from discontinued operations                  13,904      16,725
                                                            ------      ------
                                                           400,783     393,381
                                                           =======     =======
 LIABILITIES AND SHAREHOLDERS' EQUITY
 Current liabilities:
    Short-term borrowings and current
      maturities of long-term debt                        $    440      10,143
    Accounts payable                                        35,540      34,940
    Advance payments on long-term contracts, less costs
      incurred of $1,143 and $1,728, respectively            2,661       1,144
    Accrued expenses and other current liabilities          27,108      30,013
    Current liabilities from discontinued operations        10,633       9,397
                                                            ------       -----
        Total current liabilities                           76,382      85,637
                                                            ------      ------
 Deferred income                                             2,966       3,194
 Other liabilities                                          20,439      20,556
 Long-term debt                                                513         490
 Other liabilities from discontinued operations              9,395       8,115
                                                             -----       -----
        Total liabilities                                  109,695     117,992
                                                           -------     -------
 Commitments and contingencies                                  --          --
 Shareholders' equity:
     Preferred stock, par value $.01 per share,
     authorized 10,000,000 shares                               --          --
     Common stock, par value $.01 per share,
     authorized 50,000,000 shares, issued
     13,990,723 and 13,933,193 shares, respectively            140         139
    Additional paid-in capital                             218,351     216,506
    Retained earnings                                       91,807      80,292
    Accumulated other comprehensive loss                    (2,667)     (4,982)
                                                            ------      ------
                                                           307,631     291,955
    Less treasury stock, at cost: 1,103,102 and 1,105,052
    common shares, respectively                            (16,543)    (16,566)
                                                           -------     -------
        Total shareholders' equity                         291,088     275,389
                                                           -------     -------
                                                           400,783     393,381
                                                           =======     =======

See accompanying notes to consolidated financial statements.




                     ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (Unaudited)
                             (Dollars in thousands)

                                                             Six Months Ended
                                                                 March 31,


                                                         2004              2003
                                                         ----              ----
 Cash flows from operating activities:
     Net earnings                                      $11,516          12,183
     Adjustments  to reconcile  net earnings
     to net cash  provided by operating activities:
        Net loss from discontinued operations            2,637           3,629
        Depreciation and amortization                    5,904           5,796
        Changes in operating working capital             2,309          (8,455)
        Effect of deferred taxes                           186           2,912
        Other                                            1,768           3,025
                                                         -----           -----
           Net cash  provided by  operating  activities
           - continuing operations                      24,320          19,090
           Net cash used by discontinued operations     (2,246)         (3,315)
                                                        ------          ------
           Net cash provided by operating activities    22,074           15,775
 Cash flows from investing activities:
     Acquisition of business - continuing operations         -          (4,000)
     Acquisition of business - discontinued operations       -          (1,364)
     Proceeds from Riverhead note receivable              2,120              -
     Capital expenditures - continuing operations        (4,803)        (4,121)
     Capital expenditures - discontinued operations      (1,379)        (1,897)
                                                         ------         ------
     Net cash used by investing activities               (4,062)       (11,382)
                                                         ------        -------
 Cash flows from financing activities:
     Net decrease in short-term borrowings               (9,635)          (54)
     Proceeds from long-term debt                           378             -
     Principal payments on long-term debt                   (76)          (626)
     Other (including exercise of stock options)            708          1,014
                                                            ---          -----
        Net cash (used) provided by financing
        activities                                       (8,625)           334
                                                         ------            ---
 Net increase in cash and cash equivalents                9,387          4,727
 Cash and cash equivalents, beginning of period          31,285         24,930
                                                         ------         ------
 Cash and cash equivalents, end of period               $40,672         29,657
                                                        =======         ======

See accompanying notes to consolidated financial statements.




                     ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (Unaudited)

1.   BASIS OF PRESENTATION

     The  accompanying  consolidated  financial  statements,  in the  opinion of
     management,  include all  adjustments,  consisting only of normal recurring
     accruals,  necessary for a fair presentation of the results for the interim
     periods presented.  The consolidated  financial statements are presented in
     accordance  with the  requirements  of Form  10-Q and  consequently  do not
     include all the  disclosures  required by accounting  principles  generally
     accepted in the United States of America  (GAAP).  For further  information
     refer to the consolidated  financial  statements and related notes included
     in the  Company's  Annual  Report on Form 10-K for the  fiscal  year  ended
     September 30, 2003.  Certain prior year amounts have been  reclassified  to
     conform to the fiscal 2004 presentation.

     The  results for the three and six month  periods  ended March 31, 2004 are
     not necessarily indicative of the results for the entire 2004 fiscal year.


2.   DISCONTINUED OPERATIONS

     Microfiltration and Separations  Businesses  (MicroSep) - In July 2003, the
     Company  announced  its  decision to sell the  MicroSep  businesses  in the
     Filtration/Fluid  Flow  segment,  and  therefore,   these  businesses  were
     recorded as  discontinued  operations  beginning  in the fourth  quarter of
     fiscal 2003. The net sales from the MicroSep  businesses were $12.0 million
     and $10.2  million  for the  three-month  periods  ended March 31, 2004 and
     2003,  respectively  and $23.9  million and $21.2 million for the six-month
     periods  ended March 31, 2004 and 2003,  respectively.  Effective  April 2,
     2004,  the  Company  completed  the  sale  of  two of  its  three  MicroSep
     businesses.  PTI Advanced  Filtration  Inc.  (Oxnard,  California)  and PTI
     Technologies Limited (Sheffield, England) were sold to domnick hunter group
     plc for $18 million in cash.

     The major classes of discontinued  assets and  liabilities  included in the
     Consolidated  Balance  Sheets at March 31, 2004 and  September 30, 2003 are
     shown below (in thousands). The Company will retain the deferred tax assets
     shown below and plans to repay the  outstanding  long-term  borrowings with
     Bank of America (included in Other liabilities below).


                                          March 31, 2004    September 30, 2003
                                          --------------    ------------------
     Assets:
          Accounts receivable, net               $11,685                10,728
          Inventories                              9,920                 8,778
          Current portion of deferred tax assets   1,337                 1,379
          Other current assets                       463                   755
                                                     ---                   ---
               Current assets                     23,405                21,640
                                                  ------                ------
          Net property, plant & equipment         10,967                 9,096
          Deferred tax assets                      2,791                 7,493
          Other assets                               146                   136
                                                     ---                   ---
               Total assets of Discontinued
               Operations                         37,309                38,365
                                                  ======                ======

          Liabilities:
          Accounts payable                       $ 5,865                 4,522
          Accrued expenses and other current
          liabilities                              4,768                 4,875
                                                   -----                 -----
          Current liabilities                     10,633                 9,397
          Other liabilities                        9,395                 8,115
                                                   -----                 -----
               Total liabilities of Discontinued
               Operations                        $20,028                17,512
                                                 =======                ======





3.   EARNINGS PER SHARE (EPS)

     Basic EPS is calculated  using the weighted average number of common shares
     outstanding during the period. Diluted EPS is calculated using the weighted
     average number of common shares  outstanding  during the period plus shares
     issuable  upon the assumed  exercise of dilutive  common share  options and
     vesting of  performance-accelerated  restricted shares (performance shares)
     by using the  treasury  stock  method.  The  number  of shares  used in the
     calculation  of earnings per share for each period  presented is as follows
     (in thousands):

                                       Three Months Ended     Six Months Ended
                                            March 31,             March 31,
                                            ---------             ---------

                                       2004          2003     2004        2003
                                       ----          ----     ----        ----
     Weighted Average Shares
     Outstanding - Basic              12,874        12,627   12,857      12,590
     Dilutive Options and
     Performance Shares                  451           445      448         466
                                         ---           ---      ---         ---
     Adjusted Shares- Diluted         13,325        13,072   13,305      13,056
                                      ======        ======   ======      ======


     Options to purchase  104,050  shares of common stock at prices ranging from
     $45.36 - $48.58 and  options to  purchase  approximately  76,500  shares of
     common stock at prices ranging from $34.58 - $36.33 were outstanding during
     the six month periods ended March 31, 2004 and 2003, respectively, but were
     not  included  in the  computation  of diluted  EPS  because  the  options'
     exercise  prices were greater  than the average  market price of the common
     shares.  The options expire at various periods through 2014.  Approximately
     16,000 and 52,000  performance  shares were  excluded  from the  respective
     computation of diluted EPS based upon the application of the treasury stock
     method  for the  three  month  periods  ended  March  31,  2004  and  2003,
     respectively.

     In December 2002, the FASB issued SFAS No. 148  "Accounting for Stock-Based
     Compensation  - Transition and  Disclosure,  an Amendment of FASB Statement
     No. 123," (SFAS 148) to require  prominent  disclosures  in both annual and
     interim financial statements about the method of accounting for stock-based
     employee  compensation  and the  effect  of the  method  used  on  reported
     results.  The Company previously adopted the disclosure-only  provisions of
     SFAS  123.  Under  APB 25,  no  compensation  cost was  recognized  for the
     Company's stock option plans. Had compensation cost for the Company's stock
     option plans and performance  share plans been determined based on the fair
     value at the  grant  date for  awards  outstanding  during  the  three  and
     six-month  periods  ended  March  31,  2004  and 2003  consistent  with the
     provisions  of SFAS 148,  the  Company's  net earnings and net earnings per
     share would have been as shown in the table below:

        (Unaudited)
        (Dollars in thousands, except per share amounts)
                                        Three Months Ended    Six Months Ended
                                            March 31,             March 31,
                                            ---------             ---------

                                         2004       2003      2004        2003
                                         ----       ----      ----        ----
        Net earnings, as reported      $5,365      5,631    11,516      12,183
        Less: total stock-based
        employee compensation expense
        determined under fair value
        based methods, net of tax         286        617       548       1,235
                                          ---        ---       ---       -----
        Pro forma net earnings         $5,079      5,014    10,968      10,948
                                       ======      =====    ======      ======

        Net earnings per share:
            Basic - as reported        $ 0.42       0.45      0.90        0.97
            Basic - pro forma          $ 0.39       0.40      0.85        0.87
                                       ======       ====      ====        ====

            Diluted - as reported      $ 0.40       0.43      0.87        0.93
            Diluted - pro forma        $ 0.38       0.38      0.82        0.84
                                       ======       ====      ====        ====

     The fair value of each option grant is estimated on the date of grant using
     the Black-Scholes  option-pricing model with the following weighted-average
     assumptions used for grants in the three and six-month  periods ended March
     31,  2004 and 2003,  respectively:  expected  dividend  yield of 0% in both
     periods; expected volatility of 20.0% and 38.8%; risk-free interest rate of
     3.8% and 3.8%;  and expected life based on historical  exercise  periods of
     4.22 years and 4.25 years.




4.    INVENTORIES
     Inventories consist of the following (in thousands):
                                                  March 31,      September 30,
                                                    2004             2003
                                                    ----             ----

     Finished goods                               $13,578           12,449
     Work in process,
     including long- term contracts                16,126           14,611
     Raw materials                                 21,376           21,372
                                                   ------           ------
          Total inventories                       $51,080           48,432
                                                  =======           ======


5.   COMPREHENSIVE INCOME

     Comprehensive  income for the three-month  periods ended March 31, 2004 and
     2003 was $5.2 million and $5.8 million, respectively.  Comprehensive income
     for the  six-month  periods ended March 31, 2004 and 2003 was $13.8 million
     and $13.6 million,  respectively.  For the six months ended March 31, 2004,
     the  Company's  comprehensive  income was  positively  impacted  by foreign
     currency translation adjustments of approximately $2.3 million.

6.   BUSINESS SEGMENT INFORMATION

     The Company is organized based on the products and services that it offers.
     Under  this  organizational   structure,  the  Company  operates  in  three
     segments: Filtration/Fluid Flow, Communications and Test.

     Management evaluates and measures the performance of its operating segments
     based on "Net Sales" and  "EBIT",  which are  detailed in the table  below.
     EBIT is defined as earnings from continuing  operations before interest and
     taxes. Effective October 1, 2003, corporate office operating charges are no
     longer being allocated to the operating units. Previously,  corporate costs
     were allocated to the operating segments based on 2.5% of the segment's net
     sales.  The prior year  period has been  adjusted  to reflect the change in
     corporate  office  operating   charges.   "Corporate"   consists  of  those
     unallocated corporate office operating charges,  which were included in the
     "Other" operating segment in fiscal 2003 and prior periods. The table below
     is  presented  for   continuing   operations   and  excludes   discontinued
     operations.

              ($ in millions)      Three Months ended      Six Months Ended
                                         March 31,             March 31
                                         ---------             --------

      NET SALES                    2004          2003       2004       2003
      ---------                    ----          ----       ----       ----
      Filtration/Fluid Flow      $ 42.2          39.9       82.1      79.0
      Communications               30.4          37.8       61.8      77.4
      Test                         29.6          24.3       54.7      43.9
                                   ----          ----       ----      ----
      Consolidated totals        $102.2         102.0      198.6     200.3
                                 ======         =====      =====     =====

      EBIT
      Filtration/Fluid Flow      $  4.2(1)        3.4(2)     7.7(3)    9.1(2)

      Communications                7.2           9.8       14.6      20.1
      Test                          3.3           2.4        5.5       3.7
      Corporate                    (2.9)         (3.9)(4)   (5.3)     (8.0)(5)
                                   ----          ---- --    ----      ---- --

      Consolidated EBIT            11.8          11.7       22.5      24.9

      Add: Interest income          0.5           0.2        0.5       0.3
                                    ---           ---        ---       ---

      Earnings before income
      taxes                      $ 12.3          11.9       23.0      25.2
                                 ======          ====       ====      ====

          The items listed below were described in detail in previous filings.
      (1) Includes $0.6 million of exit costs related to the Filtertek Puerto
          Rico facility.
      (2) Includes a $1.5 million charge resulting from an equipment lease
          termination  related to the Whatman Hemasure MSA dispute.
      (3) Includes $1.3 million of exit costs related to the Filtertek Puerto
          Rico facility.
      (4) Includes $0.7 million of costs related to the Management  Transition
          Agreement  (MTA)
          between the Company and its former Chairman.
      (5) Includes $1.4 million of costs related to the MTA.




7.   RETIREMENT AND OTHER BENEFIT PLANS

     A summary of net periodic benefit expense for the Company's defined benefit
     plans and  postretirement  healthcare  and other benefits for the three and
     six-month  periods ended March 31, 2004 and 2003 are shown in the following
     tables. Net periodic benefit cost for each period presented is comprised of
     the following:

                                     Three Months Ended       Six Months Ended
                                           March 31,              March 31,
                                           ---------              ---------
     (Dollars in thousands)          2004          2003       2004        2003
                                     ----          ----       ----        ----
     Defined benefit plans
          Service cost              $ 140           463      $ 280       1,019
          Interest cost               623           675      1,245       1,491
          Expected return on assets  (675)         (700)    (1,350)    (1,400)
     Amortization of:
          Prior service cost           --            --         --         47
          Actuarial (gain) loss       100           112        200        318
                                      ---           ---        ---        ---
     Net periodic benefit cost      $ 188           550      $ 375      1,475
                                     ====           ===       ====      =====


     Net  periodic  postretirement  benefit  cost for each period  presented is
     comprised of the following:

                                       Three Months Ended    Six Months Ended
                                           March 31,             March 31,
                                           ---------             ---------
     (Dollars in thousands)            2004          2003    2004        2003
                                       ----          ----    ----        ----
     Service cost                      $ 11          $ 5     $ 16        $ 10
     Interest cost                       17           25       25          50
     Amortization of actuarial gain     (12)         (30)     (25)        (60)
                                        ---          ---      ---         ---
     Net periodic postretirement
     benefit cost                      $ 16          $ --    $ 16        $ --
                                       ====          ==      ====        ==


ITEM 2  MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OF  RESULTS OF OPERATIONS AND
        FINANCIAL CONDITION

RESULTS OF OPERATIONS

The  following  discussion  refers  to the  Company's  results  from  continuing
operations,  except where noted. The Microfiltration and Separations  businesses
(MicroSep) are accounted for as discontinued  operations in accordance with SFAS
No. 144,  "Accounting  for the  Impairment  or Disposal of  Long-Lived  Assets."
Accordingly, the MicroSep businesses are reflected as discontinued operations in
the financial  statements and related notes for all periods shown.  In addition,
at March 31,  2003,  Rantec  Power  Systems  Inc.  was also  accounted  for as a
discontinued operation.

NET SALES Net sales  were  $102.2  million  and  $102.0  million  for the fiscal
quarters  ended  March  31,  2004 and  2003,  respectively.  Net  sales  for the
six-month  periods ended March 31, 2004 and 2003 were $198.6  million and $200.3
million, respectively.

- -Filtration/Fluid  Flow Net sales increased $2.3 million (5.8%) to $42.2 million
for the second  quarter of fiscal 2004 from $39.9 million for the second quarter
of fiscal 2003. Net sales increased $3.1 million (3.9%) to $82.1 million for the
first six months of fiscal  2004 from $79.0  million for the first six months of
fiscal 2003. The sales  increase  during the fiscal quarter ended March 31, 2004
as compared  to the prior year  quarter is mainly due to the  following:  higher
defense  shipments  at VACCO of $1.4  million,  higher  commercial  and military
aerospace shipments at PTI of $0.6 million and a net sales increase at Filtertek
of $0.4 million  primarily  driven by the favorable  impact of foreign  currency
exchange  rates.  The sales  increase for the first six months of fiscal 2004 as
compared to the prior year period is mainly due to the following: higher defense
shipments at VACCO of $2.1 million and a net sales increase at Filtertek of $1.7
million  primarily driven by the favorable  impact of foreign currency  exchange
rates,  partially  offset  by a $0.6  million  decline  in sales  of  commercial
aerospace products.

- -Communications  For the  second  quarter  of  fiscal  2004,  net sales of $30.4
million were $7.4  million,  or 19.6% lower than the $37.8  million of net sales
recorded in the second quarter of fiscal 2003. Net sales of $61.8 million in the
first six months of fiscal  2004 were  $15.6  million,  or 20.2%  lower than the
$77.4  million  recorded  in the first six  months  of  fiscal  2003.  The sales
decreases  in the  second  quarter  of fiscal  2004 and the first six  months of
fiscal 2004 as compared to the prior year periods are the result of a decline in
shipments of Automatic  Meter Reading (AMR)  products to PPL Electric  Utilities
Corporation (PPL) as the contract is nearing completion.  Sales to PPL were $7.4
million and $15.2 million in the fiscal  quarters ended March 31, 2004 and 2003,
respectively,  and $19.9  million  and $37.8  million in the first six months of
fiscal 2004 and 2003, respectively. The PPL contract is scheduled for completion
in the fourth  quarter of fiscal 2004.  The Company  expects  sales to PPL to be
less than $1.0 million in the second half of fiscal 2004.  The decrease in sales
to PPL was  partially  offset by  significantly  higher AMR product sales to the
electric utility  cooperative  (COOP) market and other customers.  Sales to COOP
and other  customers were $22.5 million and $19.9 million in the fiscal quarters
ended March 31, 2004 and 2003,  respectively,  and were $41.0  million and $33.7
million for the first six months of fiscal 2004 and 2003, respectively.

Sales of Comtrak's SecurVision products were $0.4 million for the second quarter
of fiscal 2004 as compared to $2.7 million for the prior year second quarter and
$0.9 million for the first six months of fiscal 2004 as compared to $5.8 million
for the prior  year  six-month  period.  The  decreases  in sales for the second
quarter of fiscal 2004 and in the first six months of fiscal 2004 as compared to
the  prior  year  periods  are due to a delay in  deliveries  as a  result  of a
significant  customer requesting Comtrak to modify its software operating system
to provide enhanced "virus" protection within the product.  Normal sales volumes
are anticipated to resume during the third quarter of fiscal 2004.

- -Test Net sales  increased $5.3 million  (21.8%) to $29.6 million for the second
quarter of fiscal 2004 from $24.3 million for the second quarter of fiscal 2003.
Net sales  increased  $10.8  million  (24.6%) to $54.7 million for the first six
months of fiscal  2004 from  $43.9  million  for the first six  months of fiscal
2003.  The sales  increase  during the fiscal  quarter  ended  March 31, 2004 as
compared  to the  prior  year  quarter  is mainly  due to  higher  sales of test
chambers of  approximately  $5.7  million,  primarily  driven by two projects in
Europe.  The sales  increase for the first six months of fiscal 2004 as compared
to the prior year period is mainly due to the  following:  higher  sales of test
chambers of  approximately  $8.5  million,  primarily  driven by two projects in
Europe;  the acoustics  business (which  includes  results of operations for two
quarters in the current year  compared to one quarter in the prior year),  which
contributed  $1.7  million to the  increase in sales for the first six months of
fiscal 2004 and an  increase in sales from the  Company's  Asian  operations  of
approximately $0.5 million

ORDERS AND BACKLOG  Backlog was $259.5  million at March 31, 2004  compared with
$263.0 million at September 30, 2003. The Company  received new orders  totaling
$195.1  million  in the first six  months of fiscal  2004.  New  orders of $86.3
million  were  received  in the first  six  months of  fiscal  2004  related  to
Filtration/Fluid Flow products, $57.5 million related to Communications products
(includes $56.6 million of new orders related to AMR products, primarily for the
COOP market),  and $51.3 million related to Test products.  Backlog decreased in
the  Communications  segment due to $19.9 million of shipments to PPL during the
first six months of fiscal 2004.

COST OF SALES  Cost of sales was $70.8  million  (69.3% of net  sales) and $69.6
million  (68.3% of net sales) for the  second  quarter of fiscal  2004 and 2003,
respectively.  Cost of sales was $137.1  million (69.0% of net sales) and $136.2
million  (68.0% of net sales) for the first six months of fiscal  2004 and 2003,
respectively.  Cost of sales as a percent of net sales increased slightly in the
second  quarter  of  fiscal  2004 and the first  six  months  of fiscal  2004 as
compared  to the prior year  periods  mainly due to dual  facility  costs in the
Filtration/Fluid  Flow  segment as a result of the  closure  of the Puerto  Rico
facility  and ramp-up in Mexico and lower  margins on the  Company's  commercial
aerospace  products.  The closure and relocation of the Puerto Rico facility was
completed in March 2004.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES Selling, general and administrative
(SG&A)  expenses for the second quarter of fiscal 2004 were $19.1 million (18.7%
of net sales),  compared with $18.3  million  (18.0% of net sales) for the prior
year period.  For the first six months of fiscal 2004,  SG&A expenses were $37.9
million  (19.1% of net sales)  compared with $36.4 million  (18.2% of net sales)
for the prior year period.  The increase in SG&A spending in the fiscal  quarter
ended  March 31,  2004 and in the first six months of fiscal 2004 as compared to
the  respective  prior year periods is mainly due to the costs  associated  with
research and development,  engineering,  and marketing within the Communications
segment to further penetrate the investor owned utility market. In addition, the
acoustics  business acquired in fiscal 2003 had $0.9 million of SG&A expenses in
the first six months of fiscal 2004 (two  quarters)  compared to $0.5 million in
the prior year  period  (one  quarter).  SG&A also  includes  severance  charges
related to the closure of the Puerto Rico facility of $0.2 million in the second
quarter of fiscal 2004 and $0.5  million in the first six months of fiscal 2004.
The first six months of fiscal  2003  included  $1.4  million  of SG&A  expenses
related to the MTA, as described in previous filings.

OTHER COSTS AND EXPENSES,  NET Other costs and expenses,  net, were $0.5 million
for the quarter ended March 31, 2004 compared to $2.3 million for the prior year
quarter.  Other costs and  expenses,  net,  were $1.1  million for the first six
months of fiscal 2004  compared to $2.8 million for the prior year  period.  The
principal  component of other costs and  expenses,  net, for the fiscal  quarter
ended March 31, 2004  included  $0.5 million of exit costs related to the Puerto
Rico facility.  Principal  components of other costs and expenses,  net, for the
first six months of fiscal 2004  included  $0.9 million of exit costs related to
the Puerto  Rico  facility  and $0.5  million of  amortization  of  identifiable
intangible  assets  (primarily  patents and licenses).  Principal  components of
other costs and expenses,  net, for the first six months of fiscal 2003 included
a $1.5 million charge resulting from an equipment lease  termination  related to
the previously disclosed Whatman MSA dispute (Filtration/Fluid Flow segment) and
$0.5 million of amortization of patents and licenses.

EBIT The Company  evaluates the  performance of its operating  segments based on
EBIT,  defined below. EBIT was $11.8 million (11.5% of net sales) for the second
quarter  of fiscal  2004 and $11.7  million  (11.5% of net sales) for the second
quarter of fiscal 2003. For the first six months of fiscal 2004,  EBIT was $22.5
million  (11.3% of net  sales)  and $24.9  million  (12.4% of net sales) for the
first six months of fiscal 2003.  EBIT in the second  quarter of fiscal 2004 was
negatively impacted by the cost of sales and SG&A items mentioned earlier, which
included  $0.6  million of severance  and exit costs  related to the Puerto Rico
facility  (Filtration/Fluid  Flow  segment).  EBIT for the first  six  months of
fiscal  2004  was  negatively  impacted  by the cost of  sales  and  SG&A  items
mentioned  earlier,  which  included  $1.3 million of  severance  and exit costs
related to the Filtertek Puerto Rico facility  (Filtration/Fluid  Flow segment).
EBIT for the six-month  period ended March 31, 2003 was  negatively  impacted by
$1.4 million of MTA costs and a $1.5 million charge  resulting from an equipment
lease termination related to the Whatman Hemasure MSA dispute  (Filtration/Fluid
Flow segment).

This Form 10-Q contains the financial measure "EBIT", which is not calculated in
accordance with generally accepted accounting principles in the United States of
America  (GAAP).  EBIT provides  investors and  Management  with an  alternative
method for assessing the Company's operating results. The Company defines "EBIT"
as earnings from continuing  operations  before  interest and taxes.  Management
evaluates the  performance of its operating  segments based on EBIT and believes
that EBIT is useful to investors to demonstrate the operational profitability of
the  Company's  business  segments by excluding  interest  and taxes,  which are
generally  accounted for across the entire Company on a consolidated basis. EBIT
is also one of the measures  Management uses to determine  resource  allocations
within the Company and incentive compensation.  The following table represents a
reconciliation of EBIT to net earnings from continuing operations.



                                     Three Months ended       Six Months ended
    ($ in thousands)                      March 31,               March 31,

                                     2004          2003       2004        2003
                                     ----          ----       ----        ----
    EBIT                          $11,766       $11,729     22,509      24,881
    Add: Interest income              483           158        519         269
    Less: Income taxes              4,684         4,549      8,875       9,338
                                    -----         -----      -----       -----
    Net earnings from
    continuing operations         $ 7,565       $ 7,338    14,153       15,812
                                  =======       =======    ======       ======


- -Filtration/Fluid  Flow EBIT was $4.2  million  and $3.4  million  in the second
quarters  of  fiscal  2004 and 2003,  respectively,  and $7.7  million  and $9.1
million in the first six months of fiscal 2004 and 2003,  respectively.  For the
second  quarter  of fiscal  2004 as  compared  to the prior year  quarter,  EBIT
increased $0.8 million due to higher defense  shipments at VACCO.  For the first
six months of fiscal 2004 as compared to the prior year period,  EBIT  decreased
approximately $1.4 million due to the following:  a $1.8 million decrease at PTI
due to lower shipments of commercial aerospace products and changes in the sales
mix of military  aftermarket  products; a $1.0 million decrease at Filtertek due
to $1.3  million of exit costs  related to the Puerto Rico  facility;  partially
offset by a $1.4 million increase at VACCO due to higher defense shipments.  The
closure and  relocation of the Puerto Rico facility was completed in March 2004.
Management  expects the Puerto  Rico  facility to be sold within the next twelve
months.

- -Communications

EBIT in the second  quarter of fiscal 2004 was $7.2  million as compared to $9.8
million in the prior year period.  For the first six months of fiscal 2004, EBIT
was $14.6  million as compared to $20.1  million in the prior year  period.  The
decrease  in EBIT in the  second  quarter  of  fiscal  2004 and in the first six
months of fiscal  2004 as  compared  to the prior year  periods is mainly due to
lower  shipments of AMR equipment to PPL as the contract is nearing  completion.
The Company  continues to increase its engineering  and new product  development
expenditures  in the  Communications  segment in order to continue its growth in
the  AMR  markets,  and  to  further   differentiate  its  technology  from  the
competition.

In addition,  Comtrak's EBIT decreased  approximately $0.8 million in the second
quarter of fiscal  2004 and $1.9  million in the first six months of fiscal 2004
as compared to the respective prior year periods due to the decreased sales as a
result of the software modifications noted earlier.

- -Test

EBIT in the second  quarter of fiscal 2004 was $3.3 million as compared to
$2.4 million in the prior year period.  For the first six months of fiscal 2004,
EBIT  increased  $1.8  million to $5.5 million from $3.7 million in fiscal 2003.
The  increases  in EBIT as compared to the prior year  periods are mainly due to
the increases in sales volume.

- -Corporate

Corporate  costs included in EBIT were ($2.9) million and ($5.3) million for the
three and  six-month  periods  ended March 31, 2004,  respectively,  compared to
($3.9) million and ($8.0) million for the  respective  prior year periods.  EBIT
for the first six months of fiscal 2003 included $1.4 million of MTA costs.  The
decrease in corporate  costs for the first six months of fiscal 2004 as compared
to the  prior  year  period  is also due to  lower  operating  costs,  including
personnel related costs.

INTEREST INCOME, NET

Interest income,  net, was $0.5 million for both the three and six-month periods
ended  March  31,  2004,  compared  to $0.2  million  and $0.3  million  for the
respective  prior year periods.  The increase in interest  income for the second
quarter of fiscal 2004 and in the first six months of fiscal 2004 as compared to
the respective prior year periods is due to higher average cash balances on hand
in fiscal 2004 and the interest received on the collection of the Riverhead note
receivable, see further discussion below.

INCOME TAX EXPENSE

The second quarter  fiscal 2004 effective  income tax rate was 38.2% compared to
38.3% in the second quarter of fiscal 2003. The effective income tax rate in the
first six months of fiscal  2004 was 38.5%  compared  to 37.1% in the prior year
period. The increase in the effective income tax rate in the first six months of
fiscal 2004 is primarily due to the timing and volume of profit contributions of
the Company's foreign operations. The Company estimates the annual effective tax
rate  for  fiscal  2004  to  be  approximately  38%,  excluding  the  effect  of
discontinued operations.

CAPITAL RESOURCES AND LIQUIDITY

Working  capital  increased  to $137.8  million  at March 31,  2004 from  $120.5
million at  September  30,  2003.  During  the first six months of fiscal  2004,
accounts receivable decreased by $3.1 million due to cash collections during the
period.  Inventories increased by $2.6 million in the first six months of fiscal
2004 mainly to provide safety stock to support the facility  relocations related
to the Filtertek Puerto Rico move (Filtration/Fluid Flow segment) and to support
near term demand in the Test segment. In addition,  accounts payable and accrued
expenses  decreased  by $2.3  million  in the  first six  months of fiscal  2004
primarily due to the timing of payments.

Net cash provided by operating  activities from continuing  operations increased
$5.2 million to $24.3  million in the first six months of fiscal 2004,  compared
to $19.1 million in the same period of fiscal 2003,  mainly due to lower working
capital investments in the current period.

Capital  expenditures  from  continuing  operations  were $4.8  million and $4.1
million in the first six  months of fiscal  2004 and 2003,  respectively.  Major
expenditures in the current period included manufacturing equipment and facility
modifications  used in the  Filtration/Fluid  Flow  businesses.  The Company has
approximately $4 million in capital commitments in the Communications segment to
further  differentiate  its products and to further penetrate the investor owned
utility market. This amount will be spent within the next six months.

On February 18, 2004, the Company  received $2.1 million as final payment on the
note  receivable  from the sale of the  Riverhead,  NY property and recorded the
excess over book value of $0.3 million as interest income.

Effective  September 5, 2003, the Company amended its existing  revolving credit
facility.  The  amended  credit  facility  continues  to have $5 million  annual
reductions,  a $25 million  increase  option  through  April 11, 2004 (which has
expired) and a final  maturity and  expiration  of April 11, 2005.  At March 31,
2004,  the Company had not  exercised  the $25 million  increase  option and the
revolving  line of credit was $65 million.  At March 31,  2004,  the Company had
approximately  $52.7  million  available to borrow under the credit  facility in
addition to $40.7 million cash on hand.  Against the $65 million available under
the revolving credit facility at March 31, 2004, the Company had $9.2 million of
outstanding  long-term  borrowings  related to the Bea acquisition  (included in
"Other  liabilities from  discontinued  operations") and outstanding  letters of
credit of $3.1  million.  Cash flow from  operations  and  borrowings  under the
Company's  bank  credit  facility  are  expected to meet the  Company's  capital
requirements and operational needs for the foreseeable future.

SUBSEQUENT EVENT

Effective  April 2, 2004,  the  Company  completed  the sale of two of its three
Microfiltration and Separations (MicroSep)  businesses.  PTI Advanced Filtration
Inc. (Oxnard, California) and PTI Technologies Limited (Sheffield, England) were
sold to domnick hunter group plc for $18 million in cash.  Management expects to
complete the sale of the remaining MicroSep business,  PTI S.p.A. (Milan, Italy)
prior to September 30, 2004.  PTI S.p.A.  will continue to be accounted for as a
discontinued operation through the date of its divestiture.

CRITICAL ACCOUNTING POLICIES

The preparation of financial statements in conformity with accounting principles
generally  accepted in the United States of America requires  Management to make
estimates and assumptions in certain  circumstances that affect amounts reported
in the  accompanying  consolidated  financial  statements.  In  preparing  these
financial  statements,  Management  has made its best estimates and judgments of
certain amounts included in the financial  statements,  giving due consideration
to  materiality.  The Company does not believe there is a great  likelihood that
materially  different  amounts would be reported under  different  conditions or
using different  assumptions related to the accounting policies described below.
However,  application  of these  accounting  policies  involves  the exercise of
judgment and use of  assumptions  as to future  uncertainties  and, as a result,
actual  results  could  differ  from  these  estimates.   The  Company's  senior
Management  discusses the accounting policies described below with the Audit and
Finance Committee of the Company's Board of Directors on a periodic basis.

The following discussion of critical accounting policies is intended to bring to
the attention of readers those accounting policies which Management believes are
critical  to  the   Consolidated   Financial   Statements  and  other  financial
disclosure.  It is not intended to be a  comprehensive  list of all  significant
accounting  policies that are more fully described in Note 1 of the Notes to the
Consolidated  Financial  Statements  included in the 2003 Annual  Report on Form
10-K.

The Company has identified the following areas as critical accounting policies.

Revenue Recognition

The majority of the Company's  revenues are recognized when products are shipped
to or when  services are  performed for  unaffiliated  customers.  Other revenue
recognition  methods  the  Company  uses  include  the  following:   Revenue  on
production  contracts is recorded when specific  contract  terms are  fulfilled,
usually by delivery or acceptance.  Revenues from cost  reimbursement  contracts
are recorded as costs are incurred,  plus fees earned.  Revenue under  long-term
contracts,  for which delivery is an  inappropriate  measure of performance,  is
recognized  on the  percentage-of-completion  method based upon  incurred  costs
compared to total estimated costs under the contract.  Revenue under engineering
contracts is generally  recognized as milestones  are attained.  The Company has
certain revenue arrangements with multiple elements within the Test segment. For
such  arrangements,  the Company determines the fair value of each element under
the provisions of EITF 00-21, "Revenue Arrangements with Multiple Deliverables."
Revenue of each element is then recognized when the products and/or services are
delivered.  Revenue  arrangements with software  components are recognized under
the provisions of SOP 97-2, "Software Revenue Recognition."  Management believes
that all relevant  criteria  and  conditions  are  considered  when  recognizing
revenue.

Accounts Receivable

Accounts  receivable  have been  reduced by an  allowance  for amounts  that may
become   uncollectible.   This  estimated   allowance  is  based   primarily  on
Management's   evaluation  of  the  financial  condition  of  the  customer  and
historical bad debt experience.

Inventory

Inventories  are  valued at the lower of cost  (first-in,  first-out)  or market
value and have been reduced by an allowance for excess, slow-moving and obsolete
inventories.  The  estimated  allowance  is  based  on  Management's  review  of
inventories on hand compared to historical  usage and estimated future usage and
sales.  Inventories  under long-term  contracts reflect  accumulated  production
costs,  factory  overhead,  initial  tooling  and other  related  costs less the
portion of such costs  charged  to cost of sales and any  unliquidated  progress
payments.  In accordance with industry practice,  costs incurred on contracts in
progress  include amounts relating to programs having  production  cycles longer
than one year, and a portion thereof may not be realized within one year.

Income Taxes

Income taxes are accounted for under the asset and  liability  method.  Deferred
tax assets  and  liabilities  are  recognized  for the  future tax  consequences
attributable to differences  between the financial statement carrying amounts of
existing  assets and liabilities  and their  respective tax bases.  Deferred tax
assets and liabilities are measured using enacted tax rates expected to apply to
taxable income in the years in which those temporary differences are expected to
be  recovered  or  settled.  Deferred  tax assets may be reduced by a  valuation
allowance if it is more likely than not that some portion or all of the deferred
tax  assets  will not be  realized.  The  effect  on  deferred  tax  assets  and
liabilities  of a change in tax rates is recognized in income in the period that
includes the  enactment  date.  The Company  regularly  reviews its deferred tax
assets for recoverability and establishes a valuation  allowance when Management
believes it is more likely  than not such assets will not be  recovered,  taking
into  consideration   historical  operating  results,   expectations  of  future
earnings,  and the  expected  timing  of the  reversals  of  existing  temporary
differences.

Goodwill and Other Long-Lived Assets

The Company  adopted the  provisions of SFAS No. 142 effective  October 1, 2001.
Management annually reviews goodwill and other long-lived assets with indefinite
useful  lives for  impairment  or  whenever  events or changes in  circumstances
indicate the carrying amount may not be recoverable. If indicators of impairment
are present, the determination of the amount of impairment for long-lived assets
with definite lives is based on Management's judgment as to the future operating
cash flows to be generated from these assets  throughout  their estimated useful
lives.  SFAS No. 142 also requires that intangible  assets with estimable useful
lives  be  amortized  over  their  respective  estimated  useful  lives to their
estimated  residual values,  and reviewed for impairment in accordance with SFAS
No. 144.

Pension Plans and Other Postretirement Benefit Plans

The   measurement   of   liabilities   related  to   pension   plans  and  other
post-retirement  benefit plans is based on Management's  assumptions  related to
future events including interest rates,  return on pension plan assets,  rate of
compensation  increases,  and health care cost trend rates.  Actual pension plan
asset  performance will either decrease or increase  unamortized  pension losses
that will affect net earnings in future years. Depending upon the performance of
the equity and bond markets in 2004,  the Company  could be required to record a
charge to equity.

OTHER MATTERS

Contingencies

As a normal incident of the businesses in which the Company is engaged,  various
claims, charges and litigation are asserted or commenced against the Company. In
the opinion of  Management,  final  judgments,  if any,  which might be rendered
against the Company in current  litigation are adequately  reserved,  covered by
insurance,  or  would  not  have a  material  adverse  effect  on its  financial
statements.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

On December 23, 2003,  the FASB issued FASB  Statement  No. 132 (Revised  2003),
"Employers' Disclosures about Pensions and Other Postretirement  Benefits." This
standard  increases the existing GAAP disclosure  requirements by requiring more
detailed information about pension plan assets, benefit obligations, cash flows,
benefit costs and related  information.  Companies will be required to segregate
plan assets by category,  such as debt,  equity and real estate,  and to provide
certain  expected  rates of return  and  other  informational  disclosures.  The
provisions of this standard were adopted in the second quarter of fiscal 2004.

In December 2003, the Medicare Prescription Drug,  Improvement and Modernization
Act of 2003 (the Act)  became law in the United  States.  The Act  introduces  a
prescription  drug  benefit  under  Medicare  as well as a  federal  subsidy  to
sponsors of retiree  health care benefit plans that provide a benefit that is at
least actuarially  equivalent to the Medicare  benefit.  In accordance with FASB
Staff Position FAS 106-1, "Accounting and Disclosure Requirements Related to the
Medicare  Prescription  Drug,  Improvement and  Modernization  Act of 2003," the
Company  has  elected  to defer  recognition  of the  effects  of the Act in any
measures of the benefit obligation or cost. Specific  authoritative  guidance on
the  accounting  for the  federal  subsidy is pending  and that  guidance,  when
issued,  could require the Company to change  previously  reported  information.
Currently,  the  Company  does not  believe  it will  need to amend  its plan to
benefit from the Act.

FORWARD LOOKING STATEMENTS

Statements in this report that are not strictly historical are "forward looking"
statements  within the  meaning of the safe  harbor  provisions  of the  federal
securities  laws.  Forward  looking  statements  include  those  relating to the
estimates  made in connection  with the Company's  accounting  policies,  annual
effective tax rate,  SecurVision sales volumes,  results of sale of real estate
in Puerto Rico, results of PTI S.p.A. divestiture,  and capital requirements and
operational needs for the foreseeable future.  Investors are cautioned that such
statements are only  predictions,  and speak only as of the date of this report.
The  Company's  actual  results in the future may differ  materially  from those
projected in the forward-looking  statements due to risks and uncertainties that
exist in the Company's  operations and business environment  including,  but not
limited  to: the timing and terms of the PTI S.p.A.  divestiture;  weakening  of
economic  conditions in served markets;  changes in customer demands or customer
insolvencies;  competition;  intellectual  property  rights;  the performance of
discontinued  operations  prior to  completion  of the PTI  S.p.A.  divestiture;
successful  execution of planned sales with regard to the Company's  Puerto Rico
facility; delivery delays or defaults by customers;  termination for convenience
of  customer  contracts;   timing  and  magnitude  of  future  contract  awards;
performance issues with key suppliers and subcontractors;  collective bargaining
and  labor  disputes;  changes  in laws and  regulations  including  changes  in
accounting  standards  and  taxation  requirements;  changes  in foreign or U.S.
business  conditions  affecting  the  distribution  of foreign  earnings;  costs
relating to environmental  matters;  litigation  uncertainty;  and the Company's
successful execution of internal operating plans.

ITEM 3.       QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risks relating to the Company's  operations result primarily from changes
in interest rates and changes in foreign currency exchange rates. There has been
no material change to the Company's risks since September 30, 2003. Refer to the
Company's  2003 Annual Report on Form 10-K for further  discussion  about market
risk.



ITEM 4.       CONTROLS AND PROCEDURES

The  Company  carried  out an  evaluation,  under the  supervision  and with the
participation of Management, including the Company's Chief Executive Officer and
Chief Financial Officer, of the effectiveness of the design and operation of the
Company's disclosure controls and procedures as of the end of the period covered
by this  report.  Based upon that  evaluation,  the  Company's  Chief  Executive
Officer and Chief  Financial  Officer  concluded  that the Company's  disclosure
controls and procedures are  effective.  Disclosure  controls and procedures are
controls and procedures that are designed to ensure that information required to
be disclosed in Company reports filed or submitted under the Securities Exchange
Act of 1934 (the "Exchange Act") is recorded, processed, summarized and reported
within the time periods  specified in the Securities  and Exchange  Commission's
rules and forms. There has been no change in the Company's internal control over
financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during
the  period  covered  by this  report  that  have  materially  affected,  or are
reasonably  likely to materially  affect,  the Company's  internal  control over
financial reporting.



                            PART II OTHER INFORMATION


ITEM 6.       EXHIBITS AND REPORTS ON FORM 8-K.

a)   Exhibits
  Exhibit
  Number

 3(a) Restated Articles of            Incorporated by reference to Form 10-K
      Incorporation                   for the fiscal year ended
                                      September 30, 1999, at  Exhibit 3(a)

 3(b) Amended Certificate of          Incorporated by reference to Form 10-Q
      Designation Preferences         for the fiscal quarter ended March 31,
      and Rights of Series A          2000, at Exhibit 4(e)
      Participating Cumulative
      Preferred Stock of the
      Registrant

 3(c) Articles of Merger effective    Incorporated by reference to Form10-Q
      July 10, 2000                   for the fiscal quarter ended June 30,
                                      2000, at Exhibit  3(c)

 3(d) Bylaws, as amended and          Incorporated by reference to Form10-K
      restated.                       for the fiscal year ended September 30,
                                      2003, at  Exhibit 3.4

 4(a) Specimen Common Stock           Incorporated by reference to Form10-Q for
      Certificate                     the fiscal quarter ended June 30, 2000,
                                      at Exhibit 4(a)

 4(b) Specimen Rights Certificate     Incorporated by reference to Exhibit B to
                                      Exhibit 4.1 to the Registrant's Current
                                      Report on Form 8-K dated February 3, 2000

 4(c) Rights Agreement dated as of    Incorporated by reference to Current
      September 24, 1990 (as amended  Report on Form 8-K dated February 3,
      and Restated as of February 3,  2000, at Exhibit 4.1
      2000) between the Registrant
      and Registrar and Transfer
      Company, as successor Rights
      Agent

 4(d) Amended and Restated Credit     Incorporated by reference to Form 10-Q
      Agreement dated as of           for the fiscal quarter ended March 31,
      February 28, 2001 among the     2001, at Exhibit 4(d)
      Registrant, Bank of America,
      N.A., as agent, and the lenders
      listed therein

 4(e) Amendment No. 1 dated as of      Incorporated by reference to Form 10-Q
      April 5, 2002 to Credit          for the fiscal quarter ended June 30,
      Agreement listed as Exhibit      2002, at Exhibit 4(e).
      4(d) above.

 4(f) Amendment No. 2 and Consent      Incorporated by reference to Form 10-K
      dated as of September 5, 2003    for the fiscal year ended September 30,
      to Credit Agreement listed as    2003, at Exhibit 4(d)
      Exhibit 4(d) above

  10  2004 Incentive Compensation Plan Incorporated by reference to Notice of
                                       Annual Meeting of Stockholders and Proxy
                                       Statement dated December 29, 2003, at
                                       Appendix B

 31.1 Certification of Chief Executive
      Officer relating to Form 10-Q
      for period ended March  31, 2004

 31.2 Certification of Chief Financial
      Officer relating to Form 10-Q for
      period ended March 31, 2004

  32  Certification of Chief Executive
      Officer and Chief Financial Officer
      relating to Form 10-Q for period
      ended March 31, 2004




b)   Reports on Form 8-K.

     On February 5, 2004,  the Company filed a Current Report on Form 8-K, dated
     February  5, 2004,  which  reported  in Item 7, Item 9 and Item 12 that the
     Company was issuing a press  release that date  announcing  its fiscal 2004
     first quarter financial and operating  results,  which would be included on
     its website, and that a related conference call would be held.


SIGNATURE

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
     registrant  has duly  caused  this report to be signed on its behalf by the
     undersigned thereunto duly authorized.


                             ESCO TECHNOLOGIES INC.

                             /s/ Gary E. Muenster
                             --------------------
                              Gary E. Muenster
                              Vice President and Chief Financial Officer
                             (As duly authorized officer and principal
                              accounting officer of the registrant)





Dated:   May 11, 2004



                                  Exhibit 31.1
                                 CERTIFICATIONS

              I, V.L. Richey, Jr., certify that:

1.   I have reviewed  this  quarterly  report on Form 10-Q of ESCO  Technologies
     Inc.;

2.   Based on my knowledge,  this  quarterly  report does not contain any untrue
     statement of a material fact or omit to state a material fact  necessary to
     make the statements  made, in light of the  circumstances  under which such
     statements  were made, not misleading with respect to the period covered by
     this quarterly report;

3.   Based on my  knowledge,  the  financial  statements,  and  other  financial
     information  included  in this  quarterly  report,  fairly  present  in all
     material respects the financial  condition,  results of operations and cash
     flows of the  registrant  as of, and for,  the  periods  presented  in this
     quarterly report.

4.   The  registrant's  other  certifying  officer  and  I are  responsible  for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules  13a-15(e) and  15d-15(e))  for the registrant and we
     have:

     a.   Designed  such  disclosure  controls  and  procedures,  or caused such
          disclosure   controls  and   procedures  to  be  designed   under  our
          supervision,  to ensure  that  material  information  relating  to the
          registrant,  including its consolidated subsidiaries, is made known to
          us by others within those entities,  particularly during the period in
          which this quarterly report is being prepared;

     b.   Evaluated the  effectiveness of the registrant's  disclosure  controls
          and procedures and presented in this report our conclusions  about the
          effectiveness of the disclosure controls and procedures, as of the end
          of the period covered by this report based on such evaluation; and

     c.   Disclosed  in this  report  any  change in the  registrant's  internal
          control over financial reporting that occurred during the registrant's
          most recent fiscal quarter (the registrant's  fourth fiscal quarter in
          the case of an annual  report)  that has  materially  affected,  or is
          reasonably  likely to materially  affect,  the  registrant's  internal
          control over financial reporting; and

5.   The registrant's  other certifying  officer and I have disclosed,  based on
     our most recent evaluation of internal control over financial reporting, to
     the  registrant's  auditors  and the audit  and  finance  committee  of the
     registrant's  board of  directors  (or persons  performing  the  equivalent
     functions):

     a.   All significant  deficiencies and material weaknesses in the design or
          operation  of internal  control  over  financial  reporting  which are
          reasonably  likely to  adversely  affect the  registrant's  ability to
          record, process, summarize and report financial information; and

     b.   Any fraud, whether or not material,  that involves management or other
          employees who have a  significant  role in the  registrant's  internal
          control over financial reporting.


     Date:    May 11, 2004


                                                  (s) V.L. Richey, Jr.
                                                  --------------------
                                                      V.L. Richey, Jr.
                                                      Chief Executive Officer





                                  Exhibit 31.2
                                 CERTIFICATIONS

              I, G.E. Muenster, certify that:

1.   I have reviewed  this  quarterly  report on Form 10-Q of ESCO  Technologies
     Inc.;

2.   Based on my knowledge,  this  quarterly  report does not contain any untrue
     statement of a material fact or omit to state a material fact  necessary to
     make the statements  made, in light of the  circumstances  under which such
     statements  were made, not misleading with respect to the period covered by
     this quarterly report;

3.   Based on my  knowledge,  the  financial  statements,  and  other  financial
     information  included  in this  quarterly  report,  fairly  present  in all
     material respects the financial  condition,  results of operations and cash
     flows of the  registrant  as of, and for,  the  periods  presented  in this
     quarterly report.

4.   The  registrant's  other  certifying  officer  and  I are  responsible  for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules  13a-15(e) and  15d-15(e))  for the registrant and we
     have:

     a.   Designed  such  disclosure  controls  and  procedures,  or caused such
          disclosure   controls  and   procedures  to  be  designed   under  our
          supervision,  to ensure  that  material  information  relating  to the
          registrant,  including its consolidated subsidiaries, is made known to
          us by others within those entities,  particularly during the period in
          which this quarterly report is being prepared;

     b.   Evaluated the  effectiveness of the registrant's  disclosure  controls
          and procedures and presented in this report our conclusions  about the
          effectiveness of the disclosure controls and procedures, as of the end
          of the period covered by this report based on such evaluation; and

     c.   Disclosed  in this  report  any  change in the  registrant's  internal
          control over financial reporting that occurred during the registrant's
          most recent fiscal quarter (the registrant's  fourth fiscal quarter in
          the case of an annual  report)  that has  materially  affected,  or is
          reasonably  likely to materially  affect,  the  registrant's  internal
          control over financial reporting; and

5.   The registrant's  other certifying  officer and I have disclosed,  based on
     our most recent evaluation of internal control over financial reporting, to
     the  registrant's  auditors  and the audit  and  finance  committee  of the
     registrant's  board of  directors  (or persons  performing  the  equivalent
     functions):

     a.   All significant  deficiencies and material weaknesses in the design or
          operation  of internal  control  over  financial  reporting  which are
          reasonably  likely to  adversely  affect the  registrant's  ability to
          record, process, summarize and report financial information; and

     b.   Any fraud, whether or not material,  that involves management or other
          employees who have a  significant  role in the  registrant's  internal
          control over financial reporting.



     Date:    May 11, 2004


                                                 (s) G.E. Muenster
                                                 -----------------
                                                     G.E. Muenster
                                                     Chief Financial Officer




                                   EXHIBIT 32


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



     In connection  with the  quarterly  report of ESCO  Technologies  Inc. (the
"Company")  on Form 10-Q for the period  ended  March 31, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"),  we, V. L.
Richey, Jr., Chief Executive Officer of the Company,  and G. E. Muenster,  Chief
Financial  Officer  of the  Company,  certify,  to the  best  of our  knowledge,
pursuant to 18 U.S.C.  1350, as adopted pursuant to  906 of the Sarbanes-Oxley
Act of 2002, that:

     (1)  The Report fully  complies with the  requirements  of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of the Company.




         Dated:   May 11, 2004
                                        /s/ V.L. Richey, Jr.
                                        --------------------
                                            V.L. Richey, Jr.
                                            Chief Executive Officer
                                            ESCO Technologies Inc.

                                        /s/ G.E. Muenster
                                        -----------------
                                            G.E. Muenster
                                            Chief Financial Officer
                                            ESCO Technologies Inc.